RxDoctor Payments DataLook up a doctor →

Sanjay Yathiraj, MD

Neurology · Bradenton, FLNPI 1508851718

Payments from drug & device makers

$2,370,100in general payments, 2019–2025

Across 1,828 payments — averaging $1296.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.1M
  • Merz Pharmaceuticals, LLC$486K
  • MDD US Operations, LLC$180K
  • Eli Lilly$167K
  • AbbVie$120K
  • Sage Therapeutics, LLC$105K
  • plus $212K from 54 others
$13,280in research payments, 2019–2025

Across 6 payments — averaging $2213.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$12K
  • Eli Lilly$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis80$1,099,322
Merz Pharmaceuticals, LLC12$486,017
MDD US Operations, LLC561$180,149
Eli Lilly7$167,492
AbbVie(2 entities)177$120,274
Sage Therapeutics, LLC2$104,993
Biogen46$58,084
Sanofi6$33,436
Pacira Pharmaceuticals Incorporated20$24,013
UCB SA3$15,050
Takeda Pharmaceuticals U.S.A., Inc.28$12,879
E.r. Squibb & Sons, L.L.C.4$12,669
Acadia Pharmaceuticals Inc20$10,779
Alkermes, Inc.9$9,210
AstraZeneca(2 entities)13$6,052
Pfizer69$5,582
SK Life Science, Inc.30$5,309
Eisai Inc.35$3,486
Teva Pharmaceuticals USA, Inc.106$1,542
UCB, Inc.54$981
Neurocrine Biosciences, Inc.47$941
Jazz Pharmaceuticals Inc.47$941
Abbott8$894
GE HealthCare35$760
EMD Serono, Inc.34$752
Harmony Biosciences LLC27$742
Lilly USA, LLC34$636
CSL Behring16$475
Otsuka America Pharmaceutical, Inc.26$470
Acorda Therapeutics, Inc22$465
Sunovion Pharmaceuticals Inc.20$366
Ipsen Biopharmaceuticals, Inc1$360
Lundbeck LLC19$337
Amgen19$325
Tanabe Pharma America, Inc.16$305
Amneal Pharmaceuticals LLC11$300
Argenx US, Inc.11$290
Boston Scientific7$262
Axsome Therapeutics, Inc.7$261
Biohaven Pharmaceuticals, Inc.11$229
Catalyst Pharmaceuticals, Inc.7$201
Avanir Pharmaceuticals, Inc.10$199
Grifols USA, LLC8$187
Bristol Myers Squibb8$185
Johnson & Johnson(2 entities)9$175
Inspire Medical Systems, Inc.3$150
Genentech USA, Inc.8$150
Alnylam Pharmaceuticals Inc.8$149
Vanda Pharmaceuticals Inc.6$142
Biohaven Pharmaceutical Holding Company Ltd.6$141
Neurelis, Inc.8$137
ZOLL Respicardia, Inc.3$90
Novo Nordisk2$87
Sumitomo Pharma America, Inc.5$81
Kyowa Kirin, Inc.5$72
Avion Pharmaceuticals3$72
Nevro Corp.3$57
Livanova USA, Inc.4$56
Idorsia Pharmaceuticals US Inc3$53
Supernus Pharmaceuticals, Inc.3$40

How this compares

$2,370,100 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$1,098,534
Medicare patients
1,531
Services billed
20,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Bradenton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →